Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
fluciclovine (18f) glutamate receptor 1 small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate receptor 2 small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate receptor 3 small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate receptor 4 small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) glutamate (nmda) receptor small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved inhibitor
fluciclovine (18f) neutral amino acid transporter b(0) small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved binder
fluciclovine (18f) cationic amino acid transporter 3 small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved binder
fluciclovine (18f) y+l amino acid transporter 1 small molecule NA drugbank Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Malignant neoplasm of prostate[MeSHID:D011471]
Blood[MeSHID:D001769]
Growth[MeSHID:D006128]
Recurrence (disease attribute)[MeSHID:D012008]
NA approved binder
click here to return to the previous page